Menu
Search
Home > Courses > Bivalent & Quadrivalent Human Papillomavirus Vaccines: The Current Status & Future Prospects for HIV Prevention

Bivalent & Quadrivalent Human Papillomavirus Vaccines: The Current Status & Future Prospects for HIV Prevention

Bivalent & Quadrivalent Human Papillomavirus Vaccines: The Current Status & Future Prospects for HIV
Sorry, this learning module is not available for mobile devices.
This video is available at the Physicians Research Network website.

Original Release Date: 10/20/2009
Review Date: 10/20/2009
Presenter
  • Jennifer S. Smith, PhD, MPH
    Associate Professor
    University of North Carolina
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
  1. Review clinical trials data to explain the efficacy of current generation HPV prophylactic vaccines.
  2. Describe the association between increases in HPV infection and cervical cancer among HIV-seropositive individuals.
  3. Explain the current data on associations between HPV status and HIV acquisition.
Presenter Bio
Jennifer Smith, PhD, MPH
Jennifer S. Smith is an Associate Professor in Research within the Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina. Dr. Smith has conducted research on HPV and associated cervical neoplasia since 1995. Her current research focuses on epidemiological studies of human papillomavirus (HPV) and cervical cancer worldwide, with a focus on prevention via HPV self-screening and prophylactic vaccines.
PRN Learning Modules